Remission in schizophrenia: proposed criteria and rationale for consensus
- PMID: 15741458
- DOI: 10.1176/appi.ajp.162.3.441
Remission in schizophrenia: proposed criteria and rationale for consensus
Abstract
New advances in the understanding of schizophrenia etiology, course, and treatment have increased interest on the part of patients, families, advocates, and professionals in the development of consensus-defined standards for clinical status and improvement, including illness remission and recovery. As demonstrated in the area of mood disorders, such standards provide greater clarity around treatment goals, as well as an improved framework for the design and comparison of investigational trials and the subsequent evaluation of the effectiveness of interventions. Unlike the approach to mood disorders, however, the novel application of the concept of standard outcome criteria to schizophrenia must reflect the wide heterogeneity of its long-term course and outcome, as well as the variable effects of different treatments on schizophrenia symptoms. As an initial step in developing operational criteria, an expert working group reviewed available definitions and assessment instruments to provide a conceptual framework for symptomatic, functional, and cognitive domains in schizophrenia as they relate to remission of illness. The first consensus-based operational criteria for symptomatic remission in schizophrenia are based on distinct thresholds for reaching and maintaining improvement, as opposed to change criteria, allowing for alignment with traditional concepts of remission in both psychiatric and nonpsychiatric illness. This innovative approach for standardizing the definition for outcome in schizophrenia will require further examination of its validity and utility, as well as future refinement, particularly in relation to psychosocial and cognitive function and dysfunction. These criteria should facilitate research and support a positive, longer-term approach to studying outcome in patients with schizophrenia.
Comment in
-
Remission: what's in a name?Am J Psychiatry. 2005 Dec;162(12):2393-4; author reply 2394. doi: 10.1176/appi.ajp.162.12.2393-a. Am J Psychiatry. 2005. PMID: 16330612 No abstract available.
-
Response to Kujawa et al. letter-to-the-editor.Schizophr Res. 2006 May;84(1):172-3. doi: 10.1016/j.schres.2005.11.010. Epub 2006 Mar 24. Schizophr Res. 2006. PMID: 16563702 No abstract available.
Similar articles
-
Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application.J Clin Psychiatry. 2014;75 Suppl 1:8-14. doi: 10.4088/JCP.13049su1c.02. J Clin Psychiatry. 2014. PMID: 24581453
-
[Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].Encephale. 2013 May;39 Suppl 1:S15-21. doi: 10.1016/j.encep.2012.09.002. Epub 2013 Mar 27. Encephale. 2013. PMID: 23541143 French.
-
Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?Schizophr Bull. 2009 Mar;35(2):300-6. doi: 10.1093/schbul/sbn171. Epub 2009 Jan 6. Schizophr Bull. 2009. PMID: 19126634 Free PMC article.
-
Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.Dialogues Clin Neurosci. 2010;12(3):393-407. doi: 10.31887/DCNS.2010.12.3/mlambert. Dialogues Clin Neurosci. 2010. PMID: 20954433 Free PMC article. Review.
-
The concepts of remission and recovery in schizophrenia.Pharmacopsychiatry. 2006 Sep;39(5):161-70. doi: 10.1055/s-2006-949513. Pharmacopsychiatry. 2006. PMID: 16944406 Review.
Cited by
-
Clinical Recovery Among Individuals With a First-Episode Schizophrenia an Updated Systematic Review and Meta-Analysis.Schizophr Bull. 2023 Mar 15;49(2):297-308. doi: 10.1093/schbul/sbac103. Schizophr Bull. 2023. PMID: 36029094 Free PMC article.
-
Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study.Ind Psychiatry J. 2014 Jan;23(1):27-35. doi: 10.4103/0972-6748.144953. Ind Psychiatry J. 2014. PMID: 25535442 Free PMC article.
-
Brain functional connectivity of male patients in remission after the first episode of schizophrenia.Hum Brain Mapp. 2013 Mar;34(3):726-37. doi: 10.1002/hbm.21469. Hum Brain Mapp. 2013. PMID: 23520601 Free PMC article.
-
Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.Schizophr Bull. 2021 Mar 16;47(2):485-494. doi: 10.1093/schbul/sbaa145. Schizophr Bull. 2021. PMID: 33043960 Free PMC article.
-
Clinical predictors of therapeutic response to antipsychotics in schizophrenia.Dialogues Clin Neurosci. 2014 Dec;16(4):505-24. doi: 10.31887/DCNS.2014.16.4/mcarbon. Dialogues Clin Neurosci. 2014. PMID: 25733955 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials